The Wegovy injectable prescription weight loss medicine, sold by Novo Nordisk. Photo: Michael Siluk/UCG/Universal Images Group via Getty Images
The weight-loss drug wars are heating up, with Novo Nordisk today announcing an effective price cut on Wegovy.
The big picture: GLP-1 drugs are revolutionizing obesity treatment, but their steep price tag has prevented many people from getting them.
Driving the news: Novo is launching NovoCare Pharmacy, which will sell Wegovy for $499 per month directly to cash-paying patients who don't have insurance coverage for the treatment.